Navigating the Hurdles of a Combination Therapy Approach & the Need to Demonstrate Efficacy on Top of Existing ALS Treatments

Time: 11:05 am
day: Pre-Conference Day


In a world where numerous ALS drugs begin to exist, new challenges of trial enrolment, patient availability and an evolving standard of care emerge. Engage in forward-thinking discussions around the future of ALS drug development as increasing numbers of therapies reach the clinic:

  • How can we overcome anticipated trial complications due to varying standards of care across geographical regions?
  • What are considered optimal patient profiles for a combination therapy approach? How to select the right combination?
  • What is required to demonstrate the benefit of the combination over a single dose?
  • How must the treatment arms versus the placebo control group be handled when administering combination therapies?